Skip to main content
. Author manuscript; available in PMC: 2019 Jun 28.
Published in final edited form as: J Med Chem. 2017 Dec 28;61(12):5108–5121. doi: 10.1021/acs.jmedchem.7b01457

Figure 6.

Figure 6.

Chemical modifications of several microtubule-targeting anticancer drugs to reduce P-gp-medicated efflux. The positions of chemical modifications on Epothilone B (A), paclitaxel (B), and vinblastine (C) are indicated in small shadowed boxes. Decreased susceptibility to P-gp efflux after modifications in (B) and (C) is indicated by the lower IC50 values against various drug-resistant, P-gp overexpressing cell lines.